Pharmaceutical Business review

Daiichi Sankyo introduces Loxonin gel 1% in Japan

Loxonin gel 1% contains the same active ingredient, loxoprofen sodium hydrate as found in pills and powder formulations of the oral analgesic and anti-inflammatory Loxonin brand.

Daiichi Sankyo claimed that the Loxonin gel 1% offers equivalent efficacy and can be easily applied to an affected area with no displeasing odor.

The company said that following the launch of Loxonin pap in 2006 and Loxonin tape in 2008, it is confident that this new addition to the Loxonin lineup will further contribute to analgesic and anti-inflammatory drug treatment in Japan.